Agios wins FDA nod for targeted AML drug Tibsovo

23rd July 2018 Uncategorised 0

Agios Pharmaceuticals has scored its first FDA nod for a wholly-owned medicine, Tibsovo.

More: Agios wins FDA nod for targeted AML drug Tibsovo
Source: fierce